These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33379266)

  • 21. Vertical environmental protection pressure, fiscal pressure, and local environmental regulations: evidence from China's industrial sulfur dioxide treatment.
    Kou P; Han Y
    Environ Sci Pollut Res Int; 2021 Nov; 28(42):60095-60110. PubMed ID: 34152541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does Overseas Investment Raise Corporate Environmental Protection? Evidence from Chinese A-List Companies.
    Wang QJ; Shen Q; Geng Y; Li DY
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does digital finance promote corporate social responsibility of pollution-intensive industry? Evidence from Chinese listed companies.
    Xin D; Yi Y; Du J
    Environ Sci Pollut Res Int; 2022 Dec; 29(56):85143-85159. PubMed ID: 35790640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technical efficiency estimation of China's environmental protection enterprises and its heterogeneity.
    Wang R; Wang R; He X
    Environ Sci Pollut Res Int; 2020 Sep; 27(26):33161-33180. PubMed ID: 32529612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corporate Environmental Protection Behavior and Sustainable Development: The Moderating Role of Green Investors and Green Executive Cognition.
    Zhou J; Jin S
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of Management Structure and Resource Coordination Management Method of Construction Enterprises under Urban Environmental Pollution.
    Xing Y
    J Environ Public Health; 2022; 2022():3823835. PubMed ID: 35990549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Executive pharmaceutical background, R&D investment and corporate innovation performance.
    Zhang L; Li S; Wu M
    Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of the new Environmental Protection Law on corporate financialization in China.
    Xie G; Yang Y; Jiang K; Chen Z
    Environ Sci Pollut Res Int; 2022 Nov; 29(55):83596-83611. PubMed ID: 35764736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental regulation and corporate financialization: insight from Blue Sky Protection Campaign in China.
    Zhou Z; Xu L; Guo P; Ai H
    Environ Sci Pollut Res Int; 2023 Apr; 30(19):54993-55008. PubMed ID: 36881229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolutionary game analysis on industrial pollution control of local government in China.
    Fan W; Wang S; Gu X; Zhou Z; Zhao Y; Huo W
    J Environ Manage; 2021 Nov; 298():113499. PubMed ID: 34385115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impacts of Fiscal Subsidies on the Carbon Emissions of Mining Enterprises: Evidence from China.
    Dai W; Zhang X; Xu C
    Int J Environ Res Public Health; 2022 Dec; 19(23):. PubMed ID: 36498328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can companies get more government subsidies through improving their ESG performance? Empirical evidence from China.
    Zhang X; Zhang J; Feng Y
    PLoS One; 2023; 18(10):e0292355. PubMed ID: 37788255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tax incentives and environmental, social, and governance performance: empirical evidence from China.
    Zhu N; Zhou Y; Zhang S; Yan J
    Environ Sci Pollut Res Int; 2023 Apr; 30(19):54899-54913. PubMed ID: 36881223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Officials' promotion expectation, corporate strategic deviance and corporate growth in China: The moderating effect of corporate ownership.
    Li Y; Fang X
    PLoS One; 2023; 18(8):e0284872. PubMed ID: 37624770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How does the fiscal pressure of local governments affect China's PM2.5 emissions?
    Xu S; Zhou Y; Sun W
    Environ Sci Pollut Res Int; 2023 Jun; 30(26):69616-69627. PubMed ID: 37140862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How High-Polluting Firms Suffer from Being Distracted form Intended Purpose: A Corporate Social Responsibility Perspective.
    Zhao XZ; Chen J; Chen FW; Wang W; Xia S
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33317027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-Tasking Policy Coordination and Corporate Environmental Performance: Evidence from China.
    Xie H; Tian C; Pang F
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can China's national Five-Year Plan for environmental protection induce corporate green innovations?
    Lu H; Wang S
    Environ Sci Pollut Res Int; 2022 May; 29(23):34437-34451. PubMed ID: 35038089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of carbon emission disclosure on enterprise value under ownership heterogeneity: evidence from the heavily polluting corporations.
    Yuan L; Chen Y; He W; Kong Y; Wu X; Degefu DM; Ramsey TS
    Environ Sci Pollut Res Int; 2022 Oct; 29(46):69753-69770. PubMed ID: 35578075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of Financialization of Heavily Polluting Enterprises on Technological Innovation under the Background of Environmental Pollution Control.
    Zhou Y; Du Y; Lei F; Su Z; Feng Y; Li J
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.